Skip to main content
. Author manuscript; available in PMC: 2023 Sep 28.
Published in final edited form as: ASAIO J. 2022 Sep 28;68(6):859–864. doi: 10.1097/MAT.0000000000001575

Table II.

Incidence of Adverse Events in Infection and Infection-Free Groups

Event Infection-Free (n=46; 425 days) EPPD Infection (n=15; 482 days) EPPD P value
AKI 16 (34.8%) - 9 (64.3%) - 0.13
Dialysis 11 (23.9%) - 8 (53.3%) - 0.05
Neurological dysfunction 4 (8.7%) 0.009 1 (6.7%) 0.002 1.00
IND 1 (2.2%) 0.002 0 (0%) 0.00 1.00
HND 3 (6.5%) 0.007 1 (6.7%) 0.002 1.00
GI bleeding 4 (8.7%) 0.009 9 (60.0%) 0.02 0.001
Anticoagulation 22 (47.8%) - 12 (80.0%) - 0.04

EPPD, event per patient per day; AKI, acute kidney injury; IND, ischemic neurological dysfunction; HND, hemorrhagic neurological dysfunction; GI bleeding; gastrointestinal bleeding;